ARTICLE | Clinical News
BF-389 inhibitor of inflammatory enzymes: Began Phase I trial
November 15, 1993 8:00 AM UTC
Biofor Inc., unit of Scherer Healthcare Inc. (SCHR) Product: BF-389 inhibitor of inflammatory enzymes Indication: Arthritis Status: Began Phase I trial ...